MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Angelantonio, S.
Right arrow Articles by Nistri, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Angelantonio, S.
Right arrow Articles by Nistri, A.

Vol. 61, Issue 1, 43-54, January 2002

A Novel Class of Peptides with Facilitating Action on Neuronal Nicotinic Receptors of Rat Chromaffin Cells in Vitro: Functional and Molecular Dynamics Studies

Silvia Di Angelantonio, Valeria Costa, Paolo Carloni, Luigi Messori, and Andrea Nistri

Biophysics (S.D.A., V.C., A.N.) and Condensed Matter Sectors (P.C.) and Istituto Nazionale per la Fisica della Materia Unit (S.D.A., V.C., P.C., A.N.), International School for Advanced Studies, Trieste, Italy; and Department of Chemistry, University of Florence, Firenze, Italy (L.M.)

Peptides related to the N-terminal region of calcitonin gene-related peptide (CGRP) were tested for their ability to modulate neuronal nicotinic acetylcholine receptors (nAChRs) of rat cultured chromaffin cells under whole cell patch-clamp conditions. Although CGRP1-7 and CGRP2-7 depressed responses mediated by nAChRs, CGRP1-6, CGRP1-5, or CGRP1-4 rapidly and reversibly potentiated submaximal nicotine currents while sparing maximal currents. CGRP1-3 was inactive. The threshold concentration for the enhancing effect of CGRP1-6 was 0.1 µM. CGRP1-5 or CGRP1-4 were less effective than CGRP1-6. Coapplication of CGRP1-6 and of the allosteric potentiator physostigmine (0.5 µM) gave additive effects on nicotine currents. CGRP1-6 did not enhance responses generated by muscle-type nicotinic receptors of cultured myoblasts or by gamma -aminobutyric acidA receptors expressed by human embryonic kidney cells. Molecular dynamics (MD) simulations suggested that CGRP1-7 exhibited a relatively rigid ring structure imparted by the disulfide bridge between Cys2 and Cys7. The circular dichroism (CD) spectrum recorded from the same peptide was in agreement with this result. Shorter peptides, missing such a bridge, exhibited propensity for alpha -helix configuration. Replacing Cys7 with Ala yielded CGRP1-7A, a fragment with partial alpha -helix structure and ability to enhance nicotine currents. CD measurements on CGRP1-6 were compatible with these MD structural findings. Short terminal fragments of CGRP represent a novel class of substances with selective, rapid, and reversible potentiation of nAChRs.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
E. A. Gay, R. C. Klein, and J. L. Yakel
Apolipoprotein E-Derived Peptides Block {alpha}7 Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 835 - 842.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics